Clinical Trial Update: Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of obinutuzumab and lenalidomide in previously untreated Stage II-IV Grade 1-3a follicular lymphoma; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Gazyva (Obinutuzumab)
• Revlimid (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2025-06-08